UNSPSC 51401545: Proflazepam

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51401545

Definition

This classification denotes a benzodiazepine with the molecular formula C18H16ClFN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 545MN0F125, chemically known as 7-chloro-1-(2,3-dihydroxypropyl)-5-(o-fluorophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one but generally known as proflazepam, which bears US NIH Compound Identifier 3050433. European Medicines Agency schedules Proflazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10074MIG.

Read the full definition

The term PROFLAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). PROFLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proflazepam under HS 29339940 and SITC 51577. As of Q4 2014, PROFLAZEPAM remains the US FDA Preferred Term for this commodity. Proflazepam bears US NLM identifiers UMLS ID C1882473 and NCI Concept Code C66476. SMILES: CLC1CC2C(N(CC(O)CO)C(=O)CN=C2C2C(F)CCCC2)CC1.

About UNSPSC 51401545

UNSPSC 51401545 Proflazepam, a Commodity code, represents pharmaceutical products procured by state and local health agencies—in this case, benzodiazepine-class medications and related medical countermeasures. The recent activity under this code shows state and local governments buying naloxone and drug deactivation systems for community health initiatives, though the nominal code name (Proflazepam) does not align with the actual goods solicited. The issuing body in the recent record is a county health department operating a community health service, suggesting that procurement under this code serves public health and emergency-response functions rather than direct pharmaceutical supply to hospitals or clinics.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida. The deadline for bid submission was July 26, 2023 (note: the posted date in June 2026 and response deadline in July 2023 indicate a data-entry inconsistency in the source). Vendors were required to include all shipping and delivery costs in their proposal and comply with drug-free workplace certification, E-Verify requirements, workers' compensation insurance, and commercial general liability coverage. The contract offered an initial two-year term with a one-year renewal option and included a three-month probationary termination clause. The procurement was potentially funded through FEMA, which introduced additional federal compliance requirements such as adherence to the Clean Air Act and Federal Water Pollution Control Act. Geographic and issuing-body data are limited to this single recent Seminole County opportunity; the broader state and local procurement activity under this code cannot be characterized from the available source.

Quick answers

What is UNSPSC 51401545?

UNSPSC 51401545 is Proflazepam, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51401545?

UNSPSC 51401545 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51401545

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code